STOCK TITAN

Incyte to Report First Quarter Financial Results

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Rhea-AI Summary

Incyte has announced its first quarter financial results conference call, set for 8:00 a.m. ET on May 3, 2022. The call will follow a press release scheduled for 7:00 a.m. ET on the same day. Investors can join the conference via domestic and international dial-in numbers, with a conference ID of 13728884. A replay will be available for 30 days, and the live webcast will be accessible on Investor.Incyte.com for 90 days. Incyte focuses on developing therapeutics for unmet medical needs.

Positive
  • Scheduled Q1 2022 press release and conference call for transparency with investors.
  • Live webcast and replay options enhance accessibility for stakeholders.
Negative
  • None.

WILMINGTON, Del.--(BUSINESS WIRE)-- Incyte (Nasdaq:INCY) announced today that it has scheduled its first quarter financial results conference call and webcast for 8:00 a.m. ET on Tuesday, May 3, 2022.

The schedule for the press release and conference call/webcast is as follows:

   

• Q1 2022 Press Release:

May 3, 2022 at 7:00 a.m. ET

   

• Q1 2022 Conference Call:

May 3, 2022 at 8:00 a.m. ET

   

• Domestic Dial-In Number:

877-407-3042

   

• International Dial-In Number:

201-389-0864

   

• Conference ID Number:

13728884

If you are unable to participate, a replay of the conference call will be available for thirty days. The replay dial-in number for the U.S. is 877-660-6853 and the dial-in number for international callers is 201-612-7415. To access the replay you will need the conference ID number 13728884.

The live webcast with slides can be accessed at Investor.Incyte.com and will be available for replay for ninety days.

About Incyte

Incyte is a Wilmington, Delaware-based, global biopharmaceutical company focused on finding solutions for serious unmet medical needs through the discovery, development and commercialization of proprietary therapeutics. For additional information on Incyte, please visit Incyte.com and follow @Incyte.

Incyte

Media

Catalina Loveman

+1 302 498 6171

cloveman@incyte.com

Investors

Christine Chiou

+1 302 274 4773

cchiou@incyte.com

Source: Incyte

FAQ

When will Incyte report its Q1 2022 financial results?

Incyte will report its Q1 2022 financial results on May 3, 2022, at 7:00 a.m. ET.

What time is Incyte's Q1 2022 conference call?

The Q1 2022 conference call will take place on May 3, 2022, at 8:00 a.m. ET.

How can I access Incyte's conference call?

You can access the conference call by dialing 877-407-3042 for domestic callers or 201-389-0864 for international callers.

Is there a way to listen to a replay of Incyte's conference call?

Yes, a replay will be available for 30 days. The U.S. replay number is 877-660-6853, and the international replay number is 201-612-7415.

Where can I find the live webcast for Incyte's conference call?

The live webcast can be accessed at Investor.Incyte.com.

Incyte Genomics Inc

NASDAQ:INCY

INCY Rankings

INCY Latest News

INCY Stock Data

13.56B
188.30M
2.04%
97.86%
3.85%
Biotechnology
Services-commercial Physical & Biological Research
Link
United States of America
WILMINGTON